Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Daperno

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Internal Medicine Journal|April 20, 2021
Risk factors of SARS-CoV-2 seroprevalence among hospital employees in Italy: a single-centre studyMarco Daperno, Cristina Guiotto, Ines Casonato, et al.
Journal of Crohn'S & Colitis|December 22, 2010
The prevalence of hyper- and hypothyroidism in patients with ulcerative colitisGiovanni Casella, Elisabetta De Marco, Elisabetta Antonelli, et al.
Journal of Crohn'S & Colitis|February 8, 2022
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]Neeraj Narula, Cara Pray, Emily C L Wong, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2025
Bowel urgency in ulcerative colitis assessed from patients' reports: Results of a telemonitoring programmeEdoardo Carboni, Francesco Maria Stalla, Marco Mendolaro, et al.
Gastroenterology Research and Practice|October 1, 2019
Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi ConsensusMarco Daperno, Alessandro Armuzzi, Silvio Danese, et al.
Therapeutic Advances in Gastroenterology|February 14, 2022
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studiesCharlie W Lees, J Jasper Deuring, Michael Chiorean, et al.
Gut|March 26, 2021
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD)Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel diseaseCristina Guiotto, Marco Daperno, Francesco Frigerio, et al.
Inflammatory Bowel Diseases|March 9, 2007
Infliximab and the risk of latent viruses reactivation in active Crohn's diseaseAlessandro Lavagna, Massimiliano Bergallo, Marco Daperno, et al.
Scandinavian Journal of Gastroenterology|January 17, 2009
Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic scoreCaterina Rigazio, Elena Ercole, Cristiana Laudi, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Internal Medicine Journal|April 20, 2021
Risk factors of SARS-CoV-2 seroprevalence among hospital employees in Italy: a single-centre studyMarco Daperno, Cristina Guiotto, Ines Casonato, et al.
Journal of Crohn'S & Colitis|December 22, 2010
The prevalence of hyper- and hypothyroidism in patients with ulcerative colitisGiovanni Casella, Elisabetta De Marco, Elisabetta Antonelli, et al.
Journal of Crohn'S & Colitis|February 8, 2022
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]Neeraj Narula, Cara Pray, Emily C L Wong, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2025
Bowel urgency in ulcerative colitis assessed from patients' reports: Results of a telemonitoring programmeEdoardo Carboni, Francesco Maria Stalla, Marco Mendolaro, et al.
Gastroenterology Research and Practice|October 1, 2019
Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi ConsensusMarco Daperno, Alessandro Armuzzi, Silvio Danese, et al.
Therapeutic Advances in Gastroenterology|February 14, 2022
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studiesCharlie W Lees, J Jasper Deuring, Michael Chiorean, et al.
Gut|March 26, 2021
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD)Neeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel diseaseCristina Guiotto, Marco Daperno, Francesco Frigerio, et al.
Inflammatory Bowel Diseases|March 9, 2007
Infliximab and the risk of latent viruses reactivation in active Crohn's diseaseAlessandro Lavagna, Massimiliano Bergallo, Marco Daperno, et al.
Scandinavian Journal of Gastroenterology|January 17, 2009
Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic scoreCaterina Rigazio, Elena Ercole, Cristiana Laudi, et al.
Pageof 10